Researchers at the Harvard/Beth Israel Deaconess Medical Center are conducting a study to understand how two different medications work with specific symptoms of psychosis, and are looking for participants. The study will take place over 18 weeks and will include:
– Clinical Assessments
– Brain Activity Recording
– Blood Tests
– Tests of Cognitive Ability (such as attention, memory and problem solving)
– Treatment with Clozapine or Risperidone
Eligible participants are those who are aged between 18-60; diagnosed with schizophrenia, schizoaffective or bipolar disorder with psychotic features; do not have a neurological disorder such as traumatic brain injury or seizure disorder; and are able to tolerate clozapine treatment. Participants will be compensated for their time in the study and reimbursed for travel/parking.
For general information on this study and others see the Keshavan IMPACT Lab.
For more information on Research Opportunities, including this study see here.
For more information about this study, please contact Lola Nedic at firstname.lastname@example.org. For all other questions, please contact Bethany Yeiser at email@example.com or write us via our contact form.